Brief: Neurovive signs collaboration agreement with Karolinska Institutet
10/01/2017 07:30
Jan 10 (Reuters) - Neurovive Pharmaceutical AB NVP.ST
* Neurovive signs collaboration agreement with Karolinska
Institutet
* Says under the collaboration agreement, the team led by
Prof. Hakan Westerblad at Karolinska Institutet will study
Neurovive's cyclophilin inhibitor compound NV556 and its effects
in experimental models of mitochondrial myopathy
Source text for Eikon: ID:nWkrai4724
Further company coverage: NVP.ST
(Stockholm Newsroom)
((stockholm.newsroom@thomsonreuters.com; +46 (0)8-700 10 10;))